Operational Considerations for CAR-T Clinical Trials in Non-Oncologic Indications
Time: 12:00 pm
day: Day 1 - Track B - AM
Details:
- Holistic approach to leverage institutional experience across therapeutic areas at the site, the sponsor, and CRO
- Site capabilities and patient populations: hub-and-spoke options for patient selection and treatment
- Logistical support for autologous and allogeneic CAR-T designs: operational impact and patient considerations outside of oncology
